World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
81
Citations
41404
World Ranking
16378
National Ranking
306

Overview

Claes Held is affiliated with Uppsala University in Sweden and has a research focus primarily in the field of Medicine, with a significant emphasis on Cardiology and Cardiovascular Medicine. Their scholarly contributions span several subfields, including Surgery, Radiology, Nuclear Medicine and Imaging, Rheumatology, and Economics and Econometrics.

The scientist's research topics cover a diverse range of cardiac-related areas. These include:

  • Cardiac Health and Mental Health
  • Acute Myocardial Infarction Research
  • Cardiac Imaging and Diagnostics
  • Coronary Interventions and Diagnostics
  • Atrial Fibrillation Management and Outcomes
  • Heart Failure Treatment and Management
  • Antiplatelet Therapy and Cardiovascular Diseases

Held's recent significant publications include:

  • Initial Invasive or Conservative Strategy for Stable Coronary Disease, 2020, New England Journal of Medicine
  • Identification of vulnerable plaques and patients by intracoronary near-infrared spectroscopy and ultrasound (PROSPECT II): a prospective natural history study, 2021, The Lancet
  • Outcomes in the ISCHEMIA Trial Based on Coronary Artery Disease and Ischemia Severity, 2021, Circulation
  • Beta-Blockers after Myocardial Infarction and Preserved Ejection Fraction, 2024, New England Journal of Medicine
  • Percutaneous Coronary Intervention for Vulnerable Coronary Atherosclerotic Plaque, 2020, Journal of the American College of Cardiology

Frequent collaborators include researchers such as Lars Wallentin, Stefan James, Gorav Batra, Judith S. Hochman, and David Erlinge. These coauthors appear frequently across Held's body of work, indicating ongoing collaborative efforts.

The main venues for publication are well-established journals in cardiovascular research, including:

  • European Heart Journal
  • Circulation
  • Journal of the American College of Cardiology
  • American Heart Journal
  • European Heart Journal Acute Cardiovascular Care

Best Publications

  • Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes

    Lars Wallentin;Richard C. Becker;Andrzej Budaj;Christopher P. Cannon

  • Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction

    John J.V. McMurray;Scott D. Solomon;Silvio E. Inzucchi;Lars Køber

  • Homocysteine Lowering with Folic Acid and B Vitamins in Vascular Disease

    Eva Lonn;Salim Yusuf;J. Arnold;Janice Pogue

  • Initial invasive or conservative strategy for stable coronary disease.

    David J. Maron;Judith S. Hochman;Harmony R. Reynolds;Sripal Bangalore

  • Cholesterol Lowering in Intermediate-Risk Persons without Cardiovascular Disease

    Salim Yusuf;Jackie Bosch;Gilles Dagenais;Jun Zhu

  • Thrombin-Receptor Antagonist Vorapaxar in Acute Coronary Syndromes

    Pierluigi Tricoci;Zhen Huang;Claes Held;David J. Moliterno

  • Blood-Pressure Lowering in Intermediate-Risk Persons without Cardiovascular Disease

    Eva M. Lonn;Eva M. Lonn;Jackie Bosch;Jackie Bosch;Patricio Lopez-Jaramillo;Jun Zhu

  • Darapladib for preventing ischemic events in stable coronary heart disease.

    Harvey D. White;Claes Held;Ralph Stewart;Elizabeth Tarka

  • Association Between Adoption of Evidence-Based Treatment and Survival for Patients With ST-Elevation Myocardial Infarction

    Tomas Jernberg;Per Johanson;Claes Held;Bodil Svennblad

  • Plasma Parathyroid Hormone and the Risk of Cardiovascular Mortality in the Community

    Emil Hagström;Per Hellman;Tobias E. Larsson;Erik Ingelsson

  • The novel biomarker-based ABC (age, biomarkers, clinical history)-bleeding risk score for patients with atrial fibrillation: a derivation and validation study

    Ziad Hijazi;Jonas Oldgren;Johan Lindbäck;John H Alexander

  • Ticagrelor Compared With Clopidogrel by Geographic Region in the Platelet Inhibition and Patient Outcomes (PLATO) Trial

    Kenneth W. Mahaffey;Daniel M. Wojdyla;Kevin Carroll;Richard C. Becker

  • Ticagrelor Versus Clopidogrel in Patients With Acute Coronary Syndromes Undergoing Coronary Artery Bypass Surgery Results From the PLATO (Platelet Inhibition and Patient Outcomes) Trial

    Claes Held;Nils Åsenblad;Jean Pierre Bassand;Richard C. Becker

  • Blood-Pressure and Cholesterol Lowering in Persons without Cardiovascular Disease

    Salim Yusuf;Salim Yusuf;Eva Lonn;Eva Lonn;Prem Pais;Jackie Bosch;Jackie Bosch

  • Bleeding complications with the P2Y12 receptor antagonists clopidogrel and ticagrelor in the PLATelet inhibition and patient Outcomes (PLATO) trial.

    Richard C Becker;Jean Pierre Bassand;Andrzej Budaj;Daniel M Wojdyla

  • Risk of arrhythmias in 52 755 long-distance cross-country skiers: a cohort study

    Kasper Andersen;Bahman Farahmand;Anders Ahlbom;Claes Held

  • Efficacy and safety of apixaban compared with warfarin according to age for stroke prevention in atrial fibrillation: observations from the ARISTOTLE trial.

    Sigrun Halvorsen;Dan Atar;Dan Atar;Hongqiu Yang;Raffaele De Caterina

  • The ABC (age, biomarkers, clinical history) stroke risk score: a biomarker-based risk score for predicting stroke in atrial fibrillation

    Ziad Hijazi;Johan Lindbäck;John H. Alexander;Michael Hanna

  • Major Bleeding in Patients With Atrial Fibrillation Receiving Apixaban or Warfarin: The ARISTOTLE Trial (Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation): Predictors, Characteristics, and Clinical Outcomes

    Elaine M. Hylek;Claes Held;John H. Alexander;Renato D. Lopes

  • Improved outcomes in patients with ST-elevation myocardial infarction during the last 20 years are related to implementation of evidence-based treatments: experiences from the SWEDEHEART registry 1995-2014.

    Karolina Szummer;Karolina Szummer;Lars Wallentin;Lars Lindhagen;Joakim Alfredsson

Frequent Co-Authors

Lars Wallentin
Lars Wallentin Uppsala University
Robert A. Harrington
Robert A. Harrington Cornell University
Kenneth W. Mahaffey
Kenneth W. Mahaffey Stanford University
Stefan James
Stefan James Uppsala University
Renato D. Lopes
Renato D. Lopes Duke University
Harvey D. White
Harvey D. White Auckland City Hospital
Paul W. Armstrong
Paul W. Armstrong University of Alberta
John H. Alexander
John H. Alexander Duke University
Agneta Siegbahn
Agneta Siegbahn Uppsala University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those considering a career in medicine but exploring alternative paths or entry points, several online degree options are available. Prospective nurses, for example, can benefit from affordable rn to bsn programs that help registered nurses advance their qualifications without breaking the bank.

If you do not have a nursing background and wish to become a nurse, there are also online msn programs for non nurses designed for career changers. These programs offer direct pathways to a Master’s in Nursing, streamlining the process of entering the healthcare field.

Entry requirements can be a concern for some students. To help identify accessible programs, resources like whats the easiest nursing program to get into? provide guidance on choosing less competitive nursing schools.

For those interested in healthcare administration or support roles, medical billing and coding online schools offer accredited programs with financial aid options. These degrees can lead to rewarding, in-demand careers beyond direct patient care.

Best Scientists Citing Claes Held

Trending Scientists